Risk of bias judgements and strength of conclusions in meta-evidence from the Cochrane Colorectal Cancer Group

Abstract Background The Cochrane Collaboration records risk of bias (ROB) judgements on the original studies it analyses. The aim of this review is to perform an audit of all literature produced by the Cochrane Colorectal Cancer Group (CCCG), focusing on whether intervention type has any relationshi...

Full description

Bibliographic Details
Main Authors: John Delaney, Rebecca Cui, Alexander Engel
Format: Article
Language:English
Published: BMC 2019-04-01
Series:Systematic Reviews
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13643-019-1001-0
id doaj-5fdb382a9d554e76b2bb2b415dc02a60
record_format Article
spelling doaj-5fdb382a9d554e76b2bb2b415dc02a602020-11-25T03:54:36ZengBMCSystematic Reviews2046-40532019-04-018111610.1186/s13643-019-1001-0Risk of bias judgements and strength of conclusions in meta-evidence from the Cochrane Colorectal Cancer GroupJohn Delaney0Rebecca Cui1Alexander Engel2Northern Clinical School, Sydney Medical School, University of SydneyRoyal Prince Alfred HospitalNorthern Clinical School, Sydney Medical School, University of SydneyAbstract Background The Cochrane Collaboration records risk of bias (ROB) judgements on the original studies it analyses. The aim of this review is to perform an audit of all literature produced by the Cochrane Colorectal Cancer Group (CCCG), focusing on whether intervention type has any relationship with ROB and the ability of a review to inform clinical practice. Methods The most recent version of every CCCG review from January 2000 to the end of July 2018 was included. Conclusions were categorized as informing clinical practice (I) or not (N). Both I and N categories were divided into firm (F) or tempered (T) based on the definitiveness of their language. ROB judgements were aggregated. Reviews were classed as Medical (M), Surgical (S), Medical & Surgical (MS) or Other (O) based on their intervention, with O reviews then excluded. Data were analyzed in SPSS. Results Ninety-five reviews were included, covering 1892 studies. Sixty-two percent (n = 59/95) informed clinical practice (I). Thirty-eight percent (n = 36/95) did not inform clinical practice (N). Of the N group, 53% (n = 19/36) were completely equivocal (firm) while 47% (n = 17/36) were moderately so (tempered). In the I group, 46% (n = 27/59) gave a conclusion that was firm and 54% (n = 32/59) were tempered. Seven thousand five hundred sixty-four cases of bias were assessed. Risk of bias was low in 43%, high in 20% and unclear in 37%. A review that regarded a medical intervention alone was significantly more likely to be comprised of studies with a low risk of bias than a review that included a surgical intervention (p < 0.001). Conclusion The Cochrane Colorectal Cancer Group finds the risk of bias to be low in less than half of its judgements. A review that included a surgical intervention was less likely to display low risk of bias. Risk of bias was associated with whether a review informed clinical practice, but intervention type was not. Readers of colorectal literature should be cautious when considering original and meta-evidence in this field, particularly where a surgical intervention is assessed.http://link.springer.com/article/10.1186/s13643-019-1001-0Meta-analysisSystematic reviewCochraneRisk of biasEpidemiologic methods
collection DOAJ
language English
format Article
sources DOAJ
author John Delaney
Rebecca Cui
Alexander Engel
spellingShingle John Delaney
Rebecca Cui
Alexander Engel
Risk of bias judgements and strength of conclusions in meta-evidence from the Cochrane Colorectal Cancer Group
Systematic Reviews
Meta-analysis
Systematic review
Cochrane
Risk of bias
Epidemiologic methods
author_facet John Delaney
Rebecca Cui
Alexander Engel
author_sort John Delaney
title Risk of bias judgements and strength of conclusions in meta-evidence from the Cochrane Colorectal Cancer Group
title_short Risk of bias judgements and strength of conclusions in meta-evidence from the Cochrane Colorectal Cancer Group
title_full Risk of bias judgements and strength of conclusions in meta-evidence from the Cochrane Colorectal Cancer Group
title_fullStr Risk of bias judgements and strength of conclusions in meta-evidence from the Cochrane Colorectal Cancer Group
title_full_unstemmed Risk of bias judgements and strength of conclusions in meta-evidence from the Cochrane Colorectal Cancer Group
title_sort risk of bias judgements and strength of conclusions in meta-evidence from the cochrane colorectal cancer group
publisher BMC
series Systematic Reviews
issn 2046-4053
publishDate 2019-04-01
description Abstract Background The Cochrane Collaboration records risk of bias (ROB) judgements on the original studies it analyses. The aim of this review is to perform an audit of all literature produced by the Cochrane Colorectal Cancer Group (CCCG), focusing on whether intervention type has any relationship with ROB and the ability of a review to inform clinical practice. Methods The most recent version of every CCCG review from January 2000 to the end of July 2018 was included. Conclusions were categorized as informing clinical practice (I) or not (N). Both I and N categories were divided into firm (F) or tempered (T) based on the definitiveness of their language. ROB judgements were aggregated. Reviews were classed as Medical (M), Surgical (S), Medical & Surgical (MS) or Other (O) based on their intervention, with O reviews then excluded. Data were analyzed in SPSS. Results Ninety-five reviews were included, covering 1892 studies. Sixty-two percent (n = 59/95) informed clinical practice (I). Thirty-eight percent (n = 36/95) did not inform clinical practice (N). Of the N group, 53% (n = 19/36) were completely equivocal (firm) while 47% (n = 17/36) were moderately so (tempered). In the I group, 46% (n = 27/59) gave a conclusion that was firm and 54% (n = 32/59) were tempered. Seven thousand five hundred sixty-four cases of bias were assessed. Risk of bias was low in 43%, high in 20% and unclear in 37%. A review that regarded a medical intervention alone was significantly more likely to be comprised of studies with a low risk of bias than a review that included a surgical intervention (p < 0.001). Conclusion The Cochrane Colorectal Cancer Group finds the risk of bias to be low in less than half of its judgements. A review that included a surgical intervention was less likely to display low risk of bias. Risk of bias was associated with whether a review informed clinical practice, but intervention type was not. Readers of colorectal literature should be cautious when considering original and meta-evidence in this field, particularly where a surgical intervention is assessed.
topic Meta-analysis
Systematic review
Cochrane
Risk of bias
Epidemiologic methods
url http://link.springer.com/article/10.1186/s13643-019-1001-0
work_keys_str_mv AT johndelaney riskofbiasjudgementsandstrengthofconclusionsinmetaevidencefromthecochranecolorectalcancergroup
AT rebeccacui riskofbiasjudgementsandstrengthofconclusionsinmetaevidencefromthecochranecolorectalcancergroup
AT alexanderengel riskofbiasjudgementsandstrengthofconclusionsinmetaevidencefromthecochranecolorectalcancergroup
_version_ 1724472814529937408